These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3501228)

  • 1. Mortality in pacemaker-treated patients. A follow-up study of the impact of HLA B27 and associated rheumatic disorders.
    Bergfeldt L; Allebeck P; Edhag O
    Acta Med Scand; 1987; 222(4):293-9. PubMed ID: 3501228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pacemaker treated women with heart block have no increase in the frequency of HLA-B27 and associated rheumatic disorders in contrast to men--a sex linked difference in disease susceptibility.
    Bergfeldt L; Möller E
    J Rheumatol; 1986 Oct; 13(5):941-3. PubMed ID: 3493346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases.
    Dequeker J; Decock T; Walravens M; Van de Putte I
    J Rheumatol; 1978; 5(4):452-9. PubMed ID: 739494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA haplotypes in a family with ankylosing spondylitis and rheumatoid arthritis.
    Rantapää Dahlqvist S; Ström H; Bjelle A; Möller E
    J Rheumatol; 1985 Jun; 12(3):518-22. PubMed ID: 3876435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of HLA-B27 ankylosing spondylitis and DR4 seropositive nodular rheumatoid arthritis in patient with membranous nephropathy.
    Lemmer JP; Irby WR
    J Rheumatol; 1981; 8(4):661-4. PubMed ID: 6975378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexisting rheumatoid arthritis and ankylosing spondylitis.
    Fallet GH; Barnes CG; Berry H; Mowat AG; Roux H; Villiaumey J
    J Rheumatol; 1987 Dec; 14(6):1135-8. PubMed ID: 3437421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seronegative spondyloarthropathies in lone aortic insufficiency.
    Qaiyumi S; Hassan ZU; Toone E
    Arch Intern Med; 1985 May; 145(5):822-4. PubMed ID: 3873227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the HLA B27 test in Auckland.
    Thomas MG; Hart HH; Grigor RR; Gow PJ; Moore TE
    N Z Med J; 1984 Oct; 97(765):686-8. PubMed ID: 6333007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of HLA antigens A and B and their cross reactions in B27-negative ankylosing spondylarthritis].
    Dreyfus P; Geay D; Cambon H; Daupleix D
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):269-72. PubMed ID: 6610919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementation with HLA-A and HLA-D locus alleles in ankylosing spondylitis with peripheral arthritis.
    Aaron S; Miller ML; Howard J; Fraser PA; Jackson JM; Larson MG; Glass DN
    J Rheumatol; 1985 Jun; 12(3):553-7. PubMed ID: 3876437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of early diagnostic criteria including HLA-B27 for ankylosing spondylitis in a follow-up study.
    Zeidler H; Mau R; Mau W; Freyschmidt J; Majewski A; Deicher H
    Z Rheumatol; 1985; 44(6):249-53. PubMed ID: 3879416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Seronegative spondylo-arthropathies and HLA-B27].
    Kaludi M
    Union Med Can; 1984 Jun; 113(6):455-9, 521. PubMed ID: 6333098
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
    Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
    J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of HLA associated disease: ankylosing spondylitis.
    Hammoudeh M; Khan MA
    J Rheumatol; 1983 Apr; 10(2):301-4. PubMed ID: 6602883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance].
    Ebringer A
    Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of HLA-All in Thai seronegative spondyloarthropathies.
    Chaiamnuay P; Prichanond S; Chiewsilp P
    J Rheumatol; 1983 Oct; 10(5):790-2. PubMed ID: 6606042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis.
    Leirisalo M; Laitinen O; Tiilikainen A
    J Rheumatol Suppl; 1977; 3():78-83. PubMed ID: 266605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic significance of the occurrence of tissue antigen HLA-B27 in various rheumatic diseases].
    Kuthan F; Streda A; Parma R; Krepelková M; Hill Z; Valnícková Z
    Vnitr Lek; 1979 Jun; 25(6):578-3. PubMed ID: 313621
    [No Abstract]   [Full Text] [Related]  

  • 19. The distribution of a specific HLA-B27-associated cell surface component on the tissues of patients with ankylosing spondylitis.
    Alexander K; Edwards C; Misko IS; Geczy AF; Bashir HV; Edmonds JP
    Clin Exp Immunol; 1981 Jul; 45(1):158-64. PubMed ID: 6171370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatic disorders in a HLA B27 positive population.
    Veys EM; Mielants H; Poriau S; Verbruggen G; van der Jeught J; Dhondt E; Goethals L
    Acta Rhumatol; 1979; 3(2):176-89; discussion 189-90. PubMed ID: 11496655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.